Biomonitoring+ is a patented service that allows the determination of actual exposure to mycotoxins. The data generated help to understand the impact of these toxins on performance and health status. Only one drop of blood is needed to analyze 36 different biomarkers, including emerging mycotoxins and their metabolites. The sample is collected using an FTA card, a minimally invasive technique that facilitates the sampling process on farms.
Use
Discover actual exposure through biomarker analysis and correlate mycotoxin risk with performance and health status. The data generated allow for the proper optimization of mitigation strategies to achieve maximum performance.
Application
Biomonitoring of mycotoxin exposure using a single drop of blood. The sample is collected using a minimally invasive FTA card technique. Biomonitoring allows for the quantification of mycotoxin risk to properly implement the mitigation strategy with Escent.
Mechanism of Action
Biomonitoring+ has proven its usefulness in relation to mycotoxin exposure, observed symptoms, and performance. Identifying the
risk provides the necessary information to optimize the Escent® dosage. Escent® is the first technology shown to reduce blood mycotoxin levels, improving animal health. Additionally, it has multiple modes of action, all of which have been demonstrated in vivo:
-Support for the liver and kidneys
-Prevention of oxidative stress
-Enhanced immune response
-Increased detoxification and mycotoxin adsorption: The ability to detoxify and reduce systemic exposure, demonstrated through biomarker analysis, is particularly remarkable.
Advantages
-Generate data on real toxin risk
-Easy sampling with just one drop of blood (~ 60 μL)
-Reduced animal invasiveness
-Simplified sample transport and storage
-Improve toxin mitigation and achieve maximum potential
